After three years of study, the researchers found that alpha-synuclein, a protein closely linked to Parkinson’s disease, ...

UCLA scientists have developed advanced miniature 3D tumor organoid models that make it possible to study glioblastoma tumors in a setting that closely mirrors the human brain, shedding light on how ...

Using cortical organoids from individuals with autism, researchers tracked gene activity over development. Early ...

A new 3D human brain tissue platform developed by MIT researchers is the first to integrate all major brain cell types, including neurons, glial cells and the vasculature into a single culture. Grown ...

Neural tissue engineering aims to mimic the brain's complex environment, the extracellular matrix, which supports nerve cell growth, development, and proper connectivity. This environment is carefully ...

A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive and currently ...

Using LysoTag and proteomics, scientists built the first atlas of lysosomal proteins across neurons, astrocytes, microglia, ...

UCLA Health researchers have created a comprehensive map showing how eight different genetic mutations associated with autism ...

Scientists have discovered a molecule that shrinks brain tumors in mice, raising hopes that the compound could one day become a pill to treat glioblastoma, one of the world’s most pernicious cancers.

Researchers have created a targeted compound that blocks an enzyme linked to inflammation in individuals with a genetic predisposition to Alzheimer’s disease, while still maintaining normal brain ...

A newly identified mechanism lends credence to the idea that MS may be treatable by targeting EBV-infected B-cells, a study found.